Lucintel Forecasts The Global Uterine Cancer Diagnostics Market To Reach $11 Billion By 2030

By Author: Lucintel LLC
Total Articles: 7912
Comment this article

According to a market report by Lucintel, the future of the global uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets. The global uterine cancer diagnostics market is expected to reach an estimated $11 billion by 2030 with a CAGR of 9% from 2024 to 2030. The major drivers for this market are the increasing cases of uterine cancer, technological advancement in uterine cancer diagnostics, and the growing prevalence of obesity among women worldwide.
A more than 150-page report to understand trends, opportunity and forecast in global uterine cancer diagnostics market to 2030 by diagnostic type (instrument based and procedure based), type (endometrial cancer and uterine sarcoma), age group (60), end use (hospitals, diagnostic centers, cancer research center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the diagnostic type category, instrument based is expected to witness a higher growth over the forecast period due to evolution of diagnostic imaging technology, ...
... resulting in heightened precision.
Within the end use category, hospitals will remain the largest segment due to increasing prevalence of cancer cases, growing demand for minimally invasive advanced screening techniques, and rising investments and funding in cancer diagnostics in hospitals.
Download sample by clicking on uterine cancer diagnostics market.
In terms of regions, North America will remain the largest region over the forecast period due to growing incidence rate of uterine cancer in the US, emphasizing the significance of timely detection and preventive measures to combat cancer, and increasing number of various cancer awareness programs by the government.
Siemens Healthcare, Narang Medical, F-Hoffmann La Roche, Esaote, Samsung Medison, Olympus, Arquer Diagnostics, Guzip Biomarkers, General Electric, Canon Medical are the major suppliers in the uterine cancer diagnostics market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Exosome Extraction System Market
Extended Reach Drilling Market
Homogeneous Sterile Sampling Bag Market
Hysteroscopic Tissue Removal System Market
Identity Security Posture Management Market